Screener
Tempest Therapeutics TPST Q3 2025 earnings
Reported November 5, 2025 · Before market open
EPS-$0.79Beat by $2.48
EPS estimate-$3.27
Next report
Nov 4, 2026 (in 2 months)EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did Tempest Therapeutics report Q3 2025 earnings?
- Tempest Therapeutics (TPST) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were Tempest Therapeutics's Q3 2025 revenue and EPS?
- Tempest Therapeutics reported eps of $-0.79 for Q3 2025.
- Did Tempest Therapeutics beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-3.27 by $2.48.
- How did Tempest Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 85.2% from $-5.33.
- Where can I find Tempest Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-265937) and the 10-Q periodic report (0001193125-25-265946) directly on SEC EDGAR. The filing index links above go to sec.gov.
